The solution structures of calicheamicin yl",
aglycone of calicheamicin yI' such that its C3 and C6 proradical centers are adjacent to the cleavage sites. While the enediyne aglycone of calicheamicin y1I is tilted relative to the helix axis and spans the minor groove, the cycloaromatized aglycone is aligned approximately parallel to the helix axis in the respective complexes. Specific localized conformational perturbations in the DNA have been identified from imino proton complexation shifts and changes in specific sugar pucker patterns on complex formation. The helical parameters for the carbohydrate binding site are comparable with corresponding values in B-DNA fibers while a widening of the groove is observed at the adjacent aglycone binding site.
Calicheamicin yjI (1, Fig. 1 ) has received considerable interest from the organic chemistry community because of its architecture, important bioactivity, and intriguing mechanism of action (1) . It is a very potent tumoricidal agent that functions by efficiently cutting DNA. This is carried out by the enediyne aglycone functionality (the "warhead") of calicheamicin upon progression to a highly reactive diradical species that abstracts hydrogens from the DNA sugar backbone. Calicheamicin yli targets oligopyrimidine-oligopurine tracts with a preference for the d(T-C-C-T).d(A-G-G-A) sequence (2) (3) (4) (5) . The binding specificity has been attributed to the long aryl tetrasaccharide segment of calicheamicin yll (6) . This sector, as its methyl glycoside (2, Fig. 1 ), has been shown to competitively inhibit DNA cleavage by calicheamicin Ry)I (7, 8) as well as suppress binding of a protein transcription factor to its preferred d(T-C-C-T)-d(A-G-G-A)-containing DNA binding site (9) . An improved understanding of the contributions of the diverse array of novel functional groups in the carbohydrate recognition domain should provide a foundation for the design of the next generation of carbohydrate-based DNA binding drugs. The aryl tetrasaccharide component also has an important role in properly anchoring the warhead for sequence-selective 5C1 -A2 -C3 -T4 -C5 -C6 -17 -G8 -G9   Tl1   4:   T12   31G23 -T22 -G21 -A20 -G19 -G18 -A17 -C16 -C15^T13 FIG. 1. Ligand structures and DNA sequence used for structural studies.
double strand cleavage, since the aglycone by itself primarily generates random single strand cuts in the DNA (7) .
We report below on a combined NMR/molecular dynamics approach toward determination of a distance-refined solution structure of calicheamicin 'y)I 1 bound to DNA hairpin duplex 4 
Previous NMR structural studies on calicheamicin-DNA oligomer complexes were guided by a few intermolecular nuclear Overhauser effects (NOEs) (-15 restraints) between the drug and the DNA with the emphasis on the nonexchangeable proton data (10, 11) . By contrast, our ability to identify and assign a larger number of intermolecular NOEs ('70 restraints) using exchangeable and nonexchangeable proton data in the calicheamicin 'yI'-DNA hairpin duplex complex has permitted extension of the structural efforts to higher resolution. The resulting distance-refined structures have provided insights into the contributions of individual interactions between the drug and the DNA to the observed sequence specificity and cleavage chemistry.
In addition to the calicheamicin yj'-DNA complex, we have conducted parallel structural studies with the aryl tetrasaccharide domain 2 and the cycloaromatized analog, calicheamicin s (3, Fig. 1 ) bound to the same DNA hairpin duplex 4. Such comparative structural studies should define whether the carbohydrate components of 1, 2, and 3 bind to the same site on DNA hairpin duplex 4 and, in addition, provide insights into the orientation of the enediyne-based diradical species during the DNA cleavage process.
Abbreviations: NOE, nuclear Overhauser effect; NOESY, NOE spectroscopy; COSY, correlated spectroscopy; TOCSY, total correlated spectroscopy. §To whom reprint requests should be addressed.
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Distance and Torsional Restraints. The interproton distances were estimated from the buildup of NOE intensities as a function of mixing time. A quadratic polynomial was fitted to the data points and the initial slope was calculated from the linear fit of the quadratic curves to the first non-zero mixing time. The cytidine H5 to H6 distance of 2.48 A was used as the standard for interproton distances. The upper and lower bounds were assigned to each distance based on the residuals of the fit between the buildup data and the quadratic polynomials. The dihedral angles for the deoxyribose sugars of the DNA and the pyranose sugars of the drugs were calculated from the patterns of COSY45 cross peaks. Simulation of the cross peaks using the CHORDS program (14) provided the coupling constants, which were converted to dihedral angle restraints using a modified Karplus equation. The E torsional angle restraints were estimated from the H3'-P coupling constants, which were obtained from the H3'-selective IH-31P COSY experiment (15) .
Molecular Dynamics Calculations. The starting structure was constructed using the parameters for a B-form DNA, and the drug in an extended conformation was placed >6 A outside the minor groove. The T5 loop was not included in the structure calculations. The initial model and parameters for calicheamicin were generated using the program QUANTA (v3.3, Molecular Simulations, Waltham, MA) and converted to X-PLOR format. A total charge of + 1.0 was assigned to the drug because sugar E has a protonated ethylamino group. The starting structures were subjected to 500 steps of conjugate gradient minimization. Restrained molecular dynamics with simulated annealing was carried out in vacuum with full charges and a distance-dependent dielectric constant using the program X-PLOR (16) . All distance restraints were imposed in the form of square-well potentials. The dynamics was initiated at 5 K, and the temperature was gradually increased to 1000 K in 5.0 ps and then equilibrated for 1.0 ps. The force constants for the distance restraints were kept at 2.0 kcal mol-i.A-2 (1 kcal = 4.18 kJ) during these stages. Subsequently, the force The coordinates saved every 0.5 ps for the last 4.0 ps were averaged, and the resulting structure was minimized. All dynamics were carried out with a time step of 0.5 fs, and the force constant on the Watson-Crick hydrogen bond-related distance restraints were maintained at 60.0 kcalmol-VI.-2 throughout.
RESULTS AND DISCUSSION
NMR Spectra and Assignments. The imino proton spectral region (12.4-14.4 ppm) of the free DNA hairpin duplex 4 ( Fig.  2A ) and the one drug per duplex complexes with calicheamicin -yi 1 (Fig. 2B) , calicheamicin e 3 (Fig. 2C) , and the aryl tetrasaccharide 2 (Fig. 2D) ( Table 1 ). The calicheamicin yli'-DNA complex structure calculations were based on 70 intermolecular drug-DNA restraints with the resulting eight structures (Fig. 3) duplex (Fig. 4) . The carbohydrate segments adopt a fully extended conformation with the matching complementarity between the surfaces of the drug and the DNA minor groove excluding water molecules from this intermolecular interface.
Carbohydrate-DNA Recognition. The B-C unit of the aryl tetrasaccharide segment occupies the center of the d
(T-C-C-T).d(A-G-G-A) minor groove binding site and exhibits exten-
sive base-specific contacts with the DNA in all three complexes. The thio sugar B is positioned edgewise in the minor groove and contacts the A20 residue through van der Waals and hydrogen bonding (B ring hydroxyl to N3 of the base) interactions. The aromatic ring C is positioned between the walls of the minor groove with its iodine and CH3 groups directed toward the floor of the minor groove. These edge-on orientations of rings B and C deep in the minor groove are defined by the intermolecular NOE patterns [strong cross peak between B(H3) and A20(H2); cross peaks between the CH3 protons of ring C and the imino and exposed amino protons of G18 and G19] and the large shielding of the minor groove H4' protons of T7 and A20 ( Table 2 ) that are positioned directly over the opposite faces of the aromatic ring C. The S-carbonyl linker, which adopts an orthogonal alignment relative to the plane of ring C (favored by the steric demands of the ortho aromatic ring substituents), bridges the minor groove and makes van der Waals contacts with the opposing walls of the groove.
Schreiber and colleagues (17) (18) . Further, the amino group of the 5'-guanine in the d(A-G-G-A) segment is a critical recognition element since its replacement by inosine (lacking a 2-amino group) results in a greatly reduced binding to calicheamicin y1I (18) . These constraints are met in our solution structures of the complexes that show direct DNAto-ligand hydrogen bonding interaction between the exposed amino proton of G18 and the iodine atom of calicheamicin. In addition, the sulfur atom of the S-carbonyl linker connecting rings B and C forms an intermolecular hydrogen bond with the exposed amino proton of G19. This latter interaction was also observed in the solution structure of the esperamicin Al-DNA complex (19) . Juxtaposition of these large, polarizable iodine and sulfur atoms of calicheamicin against the floor of the minor groove induces large chemical shift changes, resulting in an -4 ppm chemical shift difference between the geminal amino protons for G18 and G19 in the d(A-G-G-A) binding site segment ( Table 2) .
The amino sugar A is aligned face down over T4 of the oligopyrimidine strand and is anchored by a potential intermolecular hydrogen bond between its hydroxyl group and the backbone phosphate at the C5-C6 step in the drug-DNA complexes. The orthogonal alignment of the adjacent A and B sugars is achieved through an eclipsed conformation at the unusual NH-O linkage (10, 11, 19) in all three complexes. The rhamnose sugar D penetrates less deeply into the minor groove and its alignment is defined, in part, by intermolecular hydrogen bonds between its hydroxyl groups (OH-2 and OH-4) and the backbone phosphates (G19-A20 and G8-G9 steps, respectively) in the complex. The E sugar straddles the sugarphosphate backbone at the d(C3-T4-C5) segment with its positively charged ethylamino group interacting with the backbone phosphate at the C3-T4 step.
Aglycone Alignment. The C2-C3-C4-C5-C6-C7 enediyne segment of the aglycone effector region of calicheamicin -yjI is positioned deep in the minor groove with its cyclic ring system bridging the sugar-phosphate backbone on partner strands. The intermolecular NOE patterns involving the enediyne H4 (6 = 6.08 ppm) and H5 (6 = 6.24 ppm) protons [cross peaks H4 to T4(H1') and H5 to T22(H1')] position them in the floor of the minor groove with the warhead spanning the groove in the complex. This alignment is anchored by a potential hydrogen bond between the hydroxyl group of C8 on the enediyne ring and the backbone phosphate at the T22-G23 step in the complex.
Our attempts to replace the C3-G21 base pair that flanks the Calicheamicin -yl cleaves both strands of duplex DNA by abstracting hydrogens from partner strands (3, 20, 21 ) that correspond to the H5' (pro S) of C5 and H4' of T22 in our DNA hairpin duplex 4. The C3 and C6 pro-radical centers of the enediyne ring are proximal to their expected abstraction sites since we measure average separations of 2.98 A (C3 to H5' of C5) and 3.22 A (C6 to H4' of T22) in our solution structure of the calicheamicin y1I-DNA hairpin duplex 4 complex. The cycloaromatized aglycone ring of calicheamicin E 3 is aligned approximately parallel to the helix axis in its complex with the DNA hairpin duplex 4 (Fig. 4C) . This may reflect the extra steric demand introduced by the H3 and H6 cycloaromatized ring protons in the calicheamicin s-DNA complex. The change in the hybridization at C1' reorients the carbamate side chain to point the carbonyl away from the groove in the calicheamicin --DNA complex, which contrasts with the horizontal orientation in the calicheamicin y,I-DNA complex. A quantitative analysis of conformational transitions associated with complex formation would require the solution structures of the free drug and free DNA in aqueous solution, which are currently unavailable. However, there are qualitative indications of local conformational perturbations in the DNA helix associated with changes in NMR parameters (chemical shifts and coupling constants) on complex formation. Thus, the imino proton of T7 shifts upfield while the imino proton of G18 shifts downfield within the d(T4-C5-C6-T7) d(A17-G18-G19-A20) segment in all three complexes (Table 2 and Fig. 2 ). Such shifts would most likely require alterations in the relative stacking of adjacent C6 G18 and T7 A17 base pairs on complex formation. Further, the imino proton of T22 at the aglycone binding site of the DNA hairpin duplex 4 shifts upfield on Chemistry: Ikemoto et al. Proc . Natl. Acad. Sci. USA 92 (1995) formation of the calicheamicin yjI 1 and calicheamicin s 3 complexes but not the aryl tetrasaccharide 2 complex. All nonterminal sugar puckers in the stem of the free DNA hairpin duplex 4 adopt C2'-endo sugar puckers in solution. By contrast, the C6 sugar at the carbohydrate binding site adopts an 04'-endo pucker in all three complexes while the T22 sugar at the aglycone binding site adopts an 04'-endo pucker only for the calicheamicin y I and calicheamicin e complexes. Finally, we detect broad cross peaks (10, 11) 
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